REVIVE Study Apps
REVIVE GastroScreen
REVIVE GastroScreen Eligibility Assessment
1 · Pepsinogens2 · Fasting G-17
3 · H. pylori IgGResult
Ⅰ
Participant & Visit InformationFormat: SITE-PARTICIPANT (e.g. 1001-001)
Confirm that the participant has not taken any proton pump inhibitor, H2 receptor antagonist, or potassium-competitive acid blocker for at least 14 days prior to this visit.
1
Step 1 — Pepsinogen PanelPGI
µg/L
PGII
µg/L
PGI:PGII Ratio AUTO
ratio
2
Step 2 — Fasting G-17 (G17b)Fasting G-17 (G17b)*
pmol/L
–
Record the fasting G-17b value. Normal range: 1–7 pmol/L. Proceed to H. pylori assessment.
Awaiting Data Entry
Enter analyte values above to generate an eligibility determination.
IMPORTANT: This tool supports — but does not replace — clinical judgement. The PI retains final authority over all eligibility determinations. REVIVE GastroScreen biomarker criteria are the primary eligibility basis. All entries subject to audit. Verify against source laboratory documentation. For investigational use only — REVIVE Study · REVIVE GastroScreen
1
Patient Demographics2
Medications & FlagsDiabetes mellitus
Blunts ammoniagenesis → longer lag
Current alkali therapy
NaHCO₃ or Na-citrate supplement
ACEi / ARB (RAASi)
Minor eGFR-stabilizing effect
Currently on chronic dialysis
Hard exclusion (HD or PD)
Prior kidney transplant
Eligible — note for clinical review
Hospitalization in past 8 weeks
May distort bicarb trajectory
3
Serial Lab Values| Date | eGFR | Bicarb | |
|---|---|---|---|
| No readings yet | |||
ℹ Minimum 2 sets of labs required to generate a trajectory. More readings improve prediction accuracy — at least 3 labs spanning ≥ 2 months is preferred.
4
Screening ParametersReady to Predict
Enter patient demographics, medications, and serial lab values on the left,
then click Run Eligibility Prediction to see the traffic light output.
Click Load Example to see the index case (bicarb 22–23 at screening).
then click Run Eligibility Prediction to see the traffic light output.
Click Load Example to see the index case (bicarb 22–23 at screening).
1
Patient Demographics2
Medications & FlagsDiabetes mellitus
Blunts ammoniagenesis → longer lag
Current alkali therapy
NaHCO₃ or Na-citrate supplement
ACEi / ARB (RAASi)
Minor eGFR-stabilizing effect
Currently on chronic dialysis
Hard exclusion (HD or PD)
Prior kidney transplant
Eligible — note for clinical review
Hospitalization in past 8 weeks
May distort bicarb trajectory
3
Serial Lab Values| Date | eGFR | Bicarb | |
|---|---|---|---|
| No readings yet | |||
ℹ Minimum 2 sets of labs required to generate a trajectory. More readings improve prediction accuracy — at least 3 labs spanning ≥ 2 months is preferred.
4
Screening ParametersReady to Predict
Enter patient demographics, medications, and serial lab values on the left,
then click Run Eligibility Prediction to see the traffic light output.
Click Load Example to see the index case (bicarb 22–23 at screening).
then click Run Eligibility Prediction to see the traffic light output.
Click Load Example to see the index case (bicarb 22–23 at screening).
Hello, World!

